Cardiol Therapeutics Inc. Files 6-K, Incorporates Exhibit
Ticker: CRDL · Form: 6-K · Filed: Jul 16, 2024 · CIK: 1702123
| Field | Detail |
|---|---|
| Company | Cardiol Therapeutics INC. (CRDL) |
| Form Type | 6-K |
| Filed Date | Jul 16, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, registration-statement, compliance
Related Tickers: CRDL
TL;DR
Cardiol Therapeutics (CRDL) filed a 6-K, incorporating an exhibit into their F-10. Standard compliance filing.
AI Summary
Cardiol Therapeutics Inc. filed a Form 6-K on July 16, 2024, incorporating Exhibit 99.1 into its existing Registration Statement on Form F-10 (File No. 333-280713). This filing relates to its ongoing reporting requirements as a foreign private issuer.
Why It Matters
This filing indicates Cardiol Therapeutics Inc. is fulfilling its regulatory obligations by incorporating an exhibit into its existing F-10 registration statement, which is relevant for investors tracking company compliance.
Risk Assessment
Risk Level: low — This is a routine regulatory filing (Form 6-K) that incorporates an exhibit into an existing registration statement, with no new financial or operational information disclosed.
Key Players & Entities
- Cardiol Therapeutics Inc. (company) — Registrant
- 6-K (document) — Form filed
- Form F-10 (document) — Registration Statement
- 333-280713 (document) — File number for Form F-10
- July 16, 2024 (date) — Filing date
FAQ
What is the purpose of this Form 6-K filing by Cardiol Therapeutics Inc.?
The purpose of this Form 6-K is to incorporate Exhibit 99.1 into the registrant's existing Registration Statement on Form F-10 (File No. 333-280713), as amended and supplemented.
What is the file number for the Registration Statement being supplemented?
The file number for the Registration Statement on Form F-10 is 333-280713.
When was this Form 6-K filed?
This Form 6-K was filed on July 16, 2024.
What type of company is Cardiol Therapeutics Inc.?
Cardiol Therapeutics Inc. is a foreign private issuer and its Standard Industrial Classification is Biological Products (No Diagnostic Substances) [2836].
Where is Cardiol Therapeutics Inc. located?
Cardiol Therapeutics Inc. is located at 602-2265 Upper Middle Road East, Oakville, Ontario L6H 0G5, Canada.
Filing Stats: 235 words · 1 min read · ~1 pages · Grade level 12 · Accepted 2024-07-16 17:25:13
Filing Documents
- tm2417421d9_6k.htm (6-K) — 12KB
- tm2417421d9_ex99-1.htm (EX-99.1) — 5KB
- tm2417421d9_ex99-1img001.jpg (GRAPHIC) — 15KB
- 0001104659-24-080254.txt ( ) — 38KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. CARDIOL THERAPEUTICS INC. (Registrant) Date: July 16, 2024 By: /s/ Chris Waddick Name: Chris Waddick Title: Chief Financial Officer Form 6-K Exhibit Index Exhibit Number Document Description 99.1 Consent of Borden Ladner Gervais LLP, dated July 16, 2024